← EU FEED
Health
LIVE · 3 in current feed
ARCHIVE
· 251–300 of 1392 page 06 of 28
Health Millions of taxpayers may be eligible for a potential IRS refund for COVID-related penalties: who qualifies and what is the deadline
Health ITM Announces Primary Results from the Phase 3 COMPETE Trial Published in The Lancet Comparing 177Lu-edotreotide (ITM-11) vs. Everolimus in Advanced GEP-NETs
Health EnteroBiotix Announces First Patient Dosed in Phase 2b RISE Study of EBX-102-02 in Irritable Bowel Syndrome with Constipation
Health CAR T-cell Therapy Market Size Forecast to USD 42.8 Billion by 2036 | Important Players are Novartis, Kite Pharma Inc. (Gilead Sciences) and more
Health Costa del Sol off-duty police officer saves six-year-old boy from choking to death on an olive
Health Alzheon to Present New Evidence of Neurovascular Protection and Preserved Brain Microstructure from Oral Valiltramiprosate Trials in APOE4/4 Alzheimer’s Patients at AAIC 2026 Conference in London
Health Cancer Tarot Horoscope Today, July 6, 2026: Financial gains and favourable conditions will prevail, auspicious news will be received
Health Shortened dual antiplatelet therapy after CABG: important evidence but unanswered questions remain
Health Pharmacogenomic Decision Engines Market May See a Big Move | Major Giants Color Genomics, Sema4, Genomic Health
Health The Power of Whole-Person Dentistry: Christopher Sprout, DDS, on Why the Mouth Is Never Just the Mouth
Health Global Injection Port Septa Market Set to Reach US$ 144.77 Million by 2034 Amid Steady 3.21% CAGR
Health Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers
Health Treos Bio Presents New Translational Data Showing PolyPEPI1018 Plus Anti-PD-L1 Immunotherapy Remodels the Tumor Immune Microenvironment in MSS Colorectal Cancer
Health Canterbury couple told son, 3, has leukaemia hours after taking him to QEQM Hospital in Margate for an infected cut finger
Health Uncomplicated Urinary Tract Infection Market Size Expected to Witness Significant Growth by 2034, estimates DelveInsight
Health Vertex Pharmaceuticals Incorporated: Vertex Announces US FDA Approval for Expanded Use of CASGEVY for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia
Health VIVAZEN® Commends the Drug Enforcement Administration’s Decision to Schedule Synthetic 7-Hydroxymitragynine (7-OH) and Three Related Drugs
Health Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease
